US Senate confirms Trump's picks to lead FDA, NIH
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
(Reuters) -The U.S. Senate on Tuesday confirmed President Donald Trump's nominees Martin Makary and Jay Bhattacharya as heads of the Food and Drug Administration and the National Institutes of Health, respectively.
The Republican-controlled Senate voted 56-44 to confirm Martin Makary as the commissioner of the FDA, which is currently embroiled in a controversy over the mass firing of federal employees.
The Senate voted 53-47 to confirm Jay Bhattacharya as director of the NIH, the nation's premier medical research agency, overseeing a nearly $50 billion budget and funding for thousands of scientific projects.
Bhattacharya is set to face immediate challenges, including legal battles over Trump's proposed cuts to federal research funding. A U.S. judge blocked the cuts earlier this month.
In the new roles, Makary and Bhattacharya will report to Health Secretary Robert F. Kennedy Jr who oversees the agencies.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
- Syria foreign minister sees Israel security talks resuming despite no trust
- Russian online retailer Ozon warehouse in Orenburg region hit in drone attack, governor says
Create E-mail Alert Related Categories
ReutersRelated Entities
Donald J. Trump, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share